Physician profile
Danielle Pieri
NPI 1982866554
$1,210.11
in general payments reported to CMS, 2019-2025
21 companies · $625 in 2025
The $625 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $31.54 · 2021: $206 · 2022: $15.00 · 2023: $70.14 · 2024: $88.99 · 2025: $625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $759 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $758.87 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $152.53 | 2019-2021 | |
| Urovant Sciences INC | $124.99 | 2021 | |
| Smith+Nephew, INC. | $107.96 | 2020-2025 | Pico 7 |
| Biogen, INC. | $96.42 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $88.52 | 2024-2025 | Veozah |
| Sage Therapeutics, LLC | $86.55 | 2024-2025 | Zurzuvae |
| Baxter Healthcare | $81.89 | 2025 | Perclot |
| Pfizer INC. | $74.69 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.65 | 2019-2023 | |
| Coopersurgical, INC. | $48.22 | 2023-2025 | Summit Doppler, Sos |
| Evofem Biosciences, INC. | $43.22 | 2021-2025 | Phexxi, Phexx, Solosec |
| Supernus Pharmaceuticals, INC. | $36.76 | 2025 | Qelbree |
| Exeltis, USA INC. | $34.48 | 2021-2024 | Slynd |
| Organon LLC | $32.52 | 2022-2025 | Nexplanon |
| Lupin INC. | $30.44 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $27.18 | 2025 | |
| Teleflex LLC | $26.84 | 2025 | Quikclot |
| Davol INC. | $21.14 | 2025 | Arista |
| Mayne Pharma Commercial LLC | $17.46 | 2025 | |
| Shield Therapeutics INC | $14.84 | 2025 | |
| Daiichi Sankyo INC. | $14.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Pieri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.